Mbv | List of Frontiers open access articles

Original Research

Published on 03 Feb 2026

Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP

in Hematologic Malignancies

Silu Cui
Panpan Luan
Yuxiao Hu
Qi Jiang

Frontiers in Oncology

doi 10.3389/fonc.2026.1747186

453 views

Original Research

Published on 03 Nov 2023

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma

in Cancer Imaging and Image-directed Interventions

Heejune So
Hyunjong Lee
Seung Hyup Hyun
Young Seok Cho
Seung Hwan Moon
Joon Young Choi
Kyung-Han Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1283582

1,845 views
3 citations

Original Research

Published on 13 Jun 2023

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

in Hematologic Malignancies

Hyun Jin
Myung Jin
Chae Hong Lim
Joon Young Choi
Seok-Jin Kim
Kyung-Han Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1186311

2,742 views
6 citations

Methods

Published on 30 Sep 2021

Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study

in Sex and Gender in Cardiovascular Medicine

Caitlin E. M. Vink
Tim P. van de Hoef
M. J. W. Götte
E. C. Eringa
Yolande Appelman

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.730810

5,989 views
10 citations

Original Research

Published on 18 Sep 2023

Unraveling the role of thermal fluctuations on the exciton structure of the cryptophyte PC612 and PC645 photosynthetic antenna complexes

in Biological Modeling and Simulation

Beste Ozaydin
Carles Curutchet

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1268278

2,499 views
3 citations

Clinical Trial

Published on 03 Aug 2022

Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial

in Infectious Diseases – Surveillance, Prevention and Treatment

Ting Zhou
Ming Yuan
Pengfei Cui
Jingjing Li
Feifei Jia
Shixuan Wang
Ronghua Liu

Frontiers in Medicine

doi 10.3389/fmed.2022.888186

5,122 views
7 citations

Original Research

Published on 23 Feb 2023

Dynamic evolution of left ventricular strain and microvascular perfusion assessed by speckle tracking echocardiography and myocardial contrast echocardiography in diabetic rats: Effect of dapagliflozin

in Cardiovascular Imaging

Juan Liu
Yixuan Wang
Jun Zhang
Xin Li
Lin Tan
Haiyun Huang
Yang Dai
Yongning Shang
Ying Shen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1109946

2,936 views
4 citations

Articles

Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

Reduced Microvascular Blood Volume as a Driver of Coronary Microvascular Disease in Patients With Non-obstructive Coronary Artery Disease: Rationale and Design of the MICORDIS Study

Unraveling the role of thermal fluctuations on the exciton structure of the cryptophyte PC612 and PC645 photosynthetic antenna complexes

Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial

Dynamic evolution of left ventricular strain and microvascular perfusion assessed by speckle tracking echocardiography and myocardial contrast echocardiography in diabetic rats: Effect of dapagliflozin